International Clinical Trial: Comparison of efficacy and safety of one and three doses of benzathine penicillin in the treatment of early syphilis: a multicenter, prospective, open-label, non-inferiority randomized controlled trial

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131878) titled 'Comparison of efficacy and safety of one and three doses of benzathine penicillin in the treatment of early syphilis: a multicenter, prospective, open-label, non-inferiority randomized controlled trial' on Sept. 7.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Institute of Dermatology and Hospital for Skin Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College

Condition: Primary Syphilis

Intervention: One-dose BPG group:One-dose BPG: Benzathine penicillin, 2.4 million U intramuscularly, once

Recruitment Status: Not Recruiting

Phase: N/A

Date of First E...